Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Return on Invested Capital (2022 - 2025)

Beam Therapeutics (BEAM) has disclosed Return on Invested Capital for 4 consecutive years, with 0.46% as the latest value for Q1 2025.

  • Quarterly Return on Invested Capital fell 27.0% to 0.46% in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 0.46% through Mar 2025, down 27.0% year-over-year, with the annual reading at 0.48% for FY2024, 27.0% down from the prior year.
  • Return on Invested Capital for Q1 2025 was 0.46% at Beam Therapeutics, up from 0.54% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.19% in Q1 2024, with the low at 0.54% in Q4 2024.
  • Average Return on Invested Capital over 4 years is 0.36%, with a median of 0.46% recorded in 2025.
  • Peak annual rise in Return on Invested Capital hit 28bps in 2024, while the deepest fall reached -34bps in 2024.
  • Over 4 years, Return on Invested Capital stood at 0.46% in 2022, then skyrocketed by 56bps to 0.2% in 2023, then crashed by -167bps to 0.54% in 2024, then increased by 15bps to 0.46% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.46%, 0.54%, and 0.22% for Q1 2025, Q4 2024, and Q3 2024 respectively.